Naproxen suppository: tissue response and comparative bioavailability.
D000284:Administration, Oral; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism* / Q000627:therapeutic use; D001702:Biopharmaceutics; D005227:Fatty Acids; D005260:Female; D006801:Humans; D008297:Male; D008738:Methyl Ethers / Q000008:administration & dosage / Q000378:metabolism; D009281:Naphthalenes / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism; D014677:Pharmaceutical Vehicles; D011092:Polyethylene Glycols; D011422:Propionates / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism*; D012002:Rectal Diseases / Q000188:drug therapy; D013488:Suppositories; D013607:Tablets; D014280:Triglycerides; D014885:Waxes
D000893:Anti-Inflammatory Agents; D005227:Fatty Acids; D008738:Methyl Ethers; D009281:Naphthalenes; D014677:Pharmaceutical Vehicles; D011422:Propionates; D013488:Suppositories; D013607:Tablets; D014280:Triglycerides; D014885:Waxes; D011092:Polyethylene Glycols